tirzepatide and mash fda Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH #VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated

Cardiovascular benefits: May reduce the risk of major adverse cardiovascular events (MACE)

JAMA (2019) 321(15):14578

By acting like the hormone GLP-1, it helps control blood sugar levels, reduces hunger, and promotes a feeling of fullness

It belongs to a novel class of agents known as triple hormone receptor agonists, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

An $11 million, 22,000-square-foot factory in Dallas is expected to be ready to roll by the end of the year

Nutritional deficiencies particularly protein, iron, and zinc can contribute to hair shedding during caloric restriction and should be assessed clinically